🔗 Visit the ClinicalTrials.gov page for NCT01210495
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Clinical trials in hepatocellular carcinoma: an update. | Liver Cancer | 2013 | 0.99 |
| 2 | Drug development: try and try again. | Nature | 2014 | 0.88 |
| 3 | Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma. | Ann Oncol | 2015 | 0.83 |
| 4 | Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations. | Therap Adv Gastroenterol | 2013 | 0.78 |
| 5 | Clinical Trial Simulations From a Model-Based Meta-Analysis of Studies in Patients With Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy. | CPT Pharmacometrics Syst Pharmacol | 2016 | 0.75 |